カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のエンブレル（エタネルセプト）バイオシミラー市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Enbrel (Etanercept) Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7843）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7843
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のエンブレル（エタネルセプト）バイオシミラー市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のエンブレル（エタネルセプト）バイオシミラーの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のエンブレル（エタネルセプト）バイオシミラー市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- エンブレル（エタネルセプト）バイオシミラーの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

エンブレル（エタネルセプト）バイオシミラー市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・シリンジ、ペン

用途別セグメント
・病院、薬局、その他

主要な市場プレーヤー
・Samsung Bioepis、Novartis、3s Bio、Lupin

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エンブレル（エタネルセプト）バイオシミラー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエンブレル（エタネルセプト）バイオシミラーメーカーの企業概要、2019年～2022年までのエンブレル（エタネルセプト）バイオシミラーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエンブレル（エタネルセプト）バイオシミラーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別エンブレル（エタネルセプト）バイオシミラーの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのエンブレル（エタネルセプト）バイオシミラーのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのエンブレル（エタネルセプト）バイオシミラー市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびエンブレル（エタネルセプト）バイオシミラーの産業チェーンを掲載しています。
・第14、15章では、エンブレル（エタネルセプト）バイオシミラーの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– エンブレル（エタネルセプト）バイオシミラーの概要
– タイプ別分析（2018年vs2022年vs2029年）：シリンジ、ペン
– 用途別分析（2018年vs2022年vs2029年）：病院、薬局、その他
– 世界のエンブレル（エタネルセプト）バイオシミラー市場規模・予測
– 世界のエンブレル（エタネルセプト）バイオシミラー生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Samsung Bioepis、Novartis、3s Bio、Lupin
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：シリンジ、ペン
・用途別分析2018年-2029年：病院、薬局、その他
・エンブレル（エタネルセプト）バイオシミラーの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・エンブレル（エタネルセプト）バイオシミラーのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・エンブレル（エタネルセプト）バイオシミラーのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エンブレル（エタネルセプト）バイオシミラーの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・エンブレル（エタネルセプト）バイオシミラーの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Enbrel (Etanercept) Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Enbrel (Etanercept) Biosimilar Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe
1.3.3 Pen
1.4 Market Analysis by Application
1.4.1 Overview: Global Enbrel (Etanercept) Biosimilar Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Global Enbrel (Etanercept) Biosimilar Market Size & Forecast
1.5.1 Global Enbrel (Etanercept) Biosimilar Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Enbrel (Etanercept) Biosimilar Sales Quantity (2018-2029)
1.5.3 Global Enbrel (Etanercept) Biosimilar Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Samsung Bioepis
2.1.1 Samsung Bioepis Details
2.1.2 Samsung Bioepis Major Business
2.1.3 Samsung Bioepis Enbrel (Etanercept) Biosimilar Product and Services
2.1.4 Samsung Bioepis Enbrel (Etanercept) Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Samsung Bioepis Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Enbrel (Etanercept) Biosimilar Product and Services
2.2.4 Novartis Enbrel (Etanercept) Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments/Updates
2.3 3s Bio
2.3.1 3s Bio Details
2.3.2 3s Bio Major Business
2.3.3 3s Bio Enbrel (Etanercept) Biosimilar Product and Services
2.3.4 3s Bio Enbrel (Etanercept) Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 3s Bio Recent Developments/Updates
2.4 Lupin
2.4.1 Lupin Details
2.4.2 Lupin Major Business
2.4.3 Lupin Enbrel (Etanercept) Biosimilar Product and Services
2.4.4 Lupin Enbrel (Etanercept) Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lupin Recent Developments/Updates
3 Competitive Environment: Enbrel (Etanercept) Biosimilar by Manufacturer
3.1 Global Enbrel (Etanercept) Biosimilar Sales Quantity by Manufacturer (2018-2023)
3.2 Global Enbrel (Etanercept) Biosimilar Revenue by Manufacturer (2018-2023)
3.3 Global Enbrel (Etanercept) Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Enbrel (Etanercept) Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Enbrel (Etanercept) Biosimilar Manufacturer Market Share in 2022
3.4.2 Top 6 Enbrel (Etanercept) Biosimilar Manufacturer Market Share in 2022
3.5 Enbrel (Etanercept) Biosimilar Market: Overall Company Footprint Analysis
3.5.1 Enbrel (Etanercept) Biosimilar Market: Region Footprint
3.5.2 Enbrel (Etanercept) Biosimilar Market: Company Product Type Footprint
3.5.3 Enbrel (Etanercept) Biosimilar Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Enbrel (Etanercept) Biosimilar Market Size by Region
4.1.1 Global Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2018-2029)
4.1.2 Global Enbrel (Etanercept) Biosimilar Consumption Value by Region (2018-2029)
4.1.3 Global Enbrel (Etanercept) Biosimilar Average Price by Region (2018-2029)
4.2 North America Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029)
4.3 Europe Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029)
4.4 Asia-Pacific Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029)
4.5 South America Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029)
4.6 Middle East and Africa Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2029)
5.2 Global Enbrel (Etanercept) Biosimilar Consumption Value by Type (2018-2029)
5.3 Global Enbrel (Etanercept) Biosimilar Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2029)
6.2 Global Enbrel (Etanercept) Biosimilar Consumption Value by Application (2018-2029)
6.3 Global Enbrel (Etanercept) Biosimilar Average Price by Application (2018-2029)
7 North America
7.1 North America Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2029)
7.2 North America Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2029)
7.3 North America Enbrel (Etanercept) Biosimilar Market Size by Country
7.3.1 North America Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2029)
7.3.2 North America Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2029)
8.2 Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2029)
8.3 Europe Enbrel (Etanercept) Biosimilar Market Size by Country
8.3.1 Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2029)
8.3.2 Europe Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Enbrel (Etanercept) Biosimilar Market Size by Region
9.3.1 Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Enbrel (Etanercept) Biosimilar Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2029)
10.2 South America Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2029)
10.3 South America Enbrel (Etanercept) Biosimilar Market Size by Country
10.3.1 South America Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2029)
10.3.2 South America Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Enbrel (Etanercept) Biosimilar Market Size by Country
11.3.1 Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Enbrel (Etanercept) Biosimilar Market Drivers
12.2 Enbrel (Etanercept) Biosimilar Market Restraints
12.3 Enbrel (Etanercept) Biosimilar Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Enbrel (Etanercept) Biosimilar and Key Manufacturers
13.2 Manufacturing Costs Percentage of Enbrel (Etanercept) Biosimilar
13.3 Enbrel (Etanercept) Biosimilar Production Process
13.4 Enbrel (Etanercept) Biosimilar Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Enbrel (Etanercept) Biosimilar Typical Distributors
14.3 Enbrel (Etanercept) Biosimilar Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Enbrel (Etanercept) Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Enbrel (Etanercept) Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 4. Samsung Bioepis Major Business
Table 5. Samsung Bioepis Enbrel (Etanercept) Biosimilar Product and Services
Table 6. Samsung Bioepis Enbrel (Etanercept) Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Samsung Bioepis Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Enbrel (Etanercept) Biosimilar Product and Services
Table 11. Novartis Enbrel (Etanercept) Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novartis Recent Developments/Updates
Table 13. 3s Bio Basic Information, Manufacturing Base and Competitors
Table 14. 3s Bio Major Business
Table 15. 3s Bio Enbrel (Etanercept) Biosimilar Product and Services
Table 16. 3s Bio Enbrel (Etanercept) Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. 3s Bio Recent Developments/Updates
Table 18. Lupin Basic Information, Manufacturing Base and Competitors
Table 19. Lupin Major Business
Table 20. Lupin Enbrel (Etanercept) Biosimilar Product and Services
Table 21. Lupin Enbrel (Etanercept) Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lupin Recent Developments/Updates
Table 23. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Enbrel (Etanercept) Biosimilar Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Enbrel (Etanercept) Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Enbrel (Etanercept) Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Enbrel (Etanercept) Biosimilar Production Site of Key Manufacturer
Table 28. Enbrel (Etanercept) Biosimilar Market: Company Product Type Footprint
Table 29. Enbrel (Etanercept) Biosimilar Market: Company Product Application Footprint
Table 30. Enbrel (Etanercept) Biosimilar New Market Entrants and Barriers to Market Entry
Table 31. Enbrel (Etanercept) Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Enbrel (Etanercept) Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Enbrel (Etanercept) Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Enbrel (Etanercept) Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Enbrel (Etanercept) Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Enbrel (Etanercept) Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Enbrel (Etanercept) Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Enbrel (Etanercept) Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Enbrel (Etanercept) Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Enbrel (Etanercept) Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Enbrel (Etanercept) Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Enbrel (Etanercept) Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Enbrel (Etanercept) Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Enbrel (Etanercept) Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Enbrel (Etanercept) Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Enbrel (Etanercept) Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Enbrel (Etanercept) Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Enbrel (Etanercept) Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Enbrel (Etanercept) Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Enbrel (Etanercept) Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Enbrel (Etanercept) Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Enbrel (Etanercept) Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Enbrel (Etanercept) Biosimilar Raw Material
Table 91. Key Manufacturers of Enbrel (Etanercept) Biosimilar Raw Materials
Table 92. Enbrel (Etanercept) Biosimilar Typical Distributors
Table 93. Enbrel (Etanercept) Biosimilar Typical Customers
List of Figures
Figure 1. Enbrel (Etanercept) Biosimilar Picture
Figure 2. Global Enbrel (Etanercept) Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Type in 2022
Figure 4. Syringe Examples
Figure 5. Pen Examples
Figure 6. Global Enbrel (Etanercept) Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Other Examples
Figure 11. Global Enbrel (Etanercept) Biosimilar Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Enbrel (Etanercept) Biosimilar Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Enbrel (Etanercept) Biosimilar Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Enbrel (Etanercept) Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Enbrel (Etanercept) Biosimilar by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Enbrel (Etanercept) Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Enbrel (Etanercept) Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Enbrel (Etanercept) Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Enbrel (Etanercept) Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Enbrel (Etanercept) Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 53. China Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Enbrel (Etanercept) Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Enbrel (Etanercept) Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Enbrel (Etanercept) Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Enbrel (Etanercept) Biosimilar Market Drivers
Figure 74. Enbrel (Etanercept) Biosimilar Market Restraints
Figure 75. Enbrel (Etanercept) Biosimilar Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Enbrel (Etanercept) Biosimilar in 2022
Figure 78. Manufacturing Process Analysis of Enbrel (Etanercept) Biosimilar
Figure 79. Enbrel (Etanercept) Biosimilar Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のチロゲン&バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアバスチンバイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のベバシズマブモノクローナル抗体バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアダリムマブモノクローナル抗体バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7843 )"世界のエンブレル（エタネルセプト）バイオシミラー市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Enbrel (Etanercept) Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。